Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN category
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN category ; volume:14 ; number:1 ; day:7 ; month:2 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (7.2.2024), 1-9, 12.2024
- Urheber
-
Yamazaki, Hideya
Suzuki, Gen
Aibe, Norihiro
Shiomi, Hiroya
Oh, Ryoong-jin
Yoshida, Ken
Nakamura, Satoaki
Konishi, Koji
Matsuyama, Tomohiko
Ogita, Mikio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-53438-w
- URN
-
urn:nbn:de:101:1-2404160814416.911056389353
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yamazaki, Hideya
- Suzuki, Gen
- Aibe, Norihiro
- Shiomi, Hiroya
- Oh, Ryoong-jin
- Yoshida, Ken
- Nakamura, Satoaki
- Konishi, Koji
- Matsuyama, Tomohiko
- Ogita, Mikio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
Post-radiation sarcoma of the neck treated with re-irradiation followed by wide excision
Re-irradiation: new frontiers
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy
Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
Expert consensus on re-irradiation for recurrent glioma
Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
Post-radiation sarcoma of the neck treated with re-irradiation followed by wide excision
Re-irradiation: new frontiers
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy
Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
Expert consensus on re-irradiation for recurrent glioma
Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
Post-radiation sarcoma of the neck treated with re-irradiation followed by wide excision
Re-irradiation: new frontiers
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy
Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy